Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-62,642
Closed -$3.03M 801
2025
Q2
$3.03M Buy
+62,642
New +$3.2M 0.27% 106
2024
Q4
Sell
-26,194
Closed -$1.51M 625
2024
Q3
$1.51M Sell
26,194
-90,768
-78% -$4.9M 0.16% 192
2024
Q2
$5.67M Buy
116,962
+109,759
+1,524% +$5.29M 0.57% 49
2024
Q1
$350K Sell
7,203
-36,209
-83% -$1.77M 0.04% 386
2023
Q4
$2.16M Buy
+43,412
New +$2.12M 0.38% 83

Other funds holding SNY

Atom Investors's SNY Position: Q3 2025 in Review

Atom Investors sold out of Sanofi (SNY) in Q3 2025, closing a stake of 62,642 shares — an estimated $3.03M sold.

Atom Investors first reported a position in SNY in Q4 2023 and held it in 5 quarters. The position peaked at $5.67M in Q2 2024. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Atom Investors reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Atom Investors sold 62,642 Sanofi shares in Q3 2025, an estimated $3.03M.
  • Atom Investors first reported a position in Sanofi in Q4 2023 and held it in 5 quarters.
  • Atom Investors's Sanofi position peaked at $5.67M in Q2 2024.
  • 712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.